AcelRx Pharmaceuticals
ACRX
$0.56
Share price
-2.42%
Change (1 day)
-87.16%
Change (1 year)
Categories
AcelRx Pharmaceuticals (ACRX) - Cash on Hand
Cash on Hand as of June 2023 : $7.41 M
According to AcelRx Pharmaceuticals
's latest financial reports the company has $7.41 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
AcelRx Pharmaceuticals - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $15.77 M | -69.46% |
| 2021-12-31 | $51.63 M | 20.39% |
| 2020-12-31 | $42.88 M | -35.16% |
| 2019-12-31 | $66.13 M | -37.44% |
| 2018-12-31 | $0.10 B | 74.83% |
| 2017-12-31 | $60.46 M | -24.71% |
| 2016-12-31 | $80.31 M | -29.22% |
| 2015-12-31 | $0.11 B | 50.58% |
| 2014-12-31 | $75.35 M | -27.31% |
| 2013-12-31 | $0.10 B | 73.46% |
| 2012-12-31 | $59.76 M | 67.01% |
| 2011-12-31 | $35.78 M | 871.89% |
| 2010-12-31 | $3.68 M | -70.65% |
| 2009-12-31 | $12.54 M | -37.91% |
| 2008-12-31 | $20.2 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Cara Therapeutics
CARA | $94.69 M | 1,177.88% | 🇺🇸 USA |